Aptose Biosciences (APTO) announced that its board of directors has approved, subject to required regulatory and stock exchange approvals, a ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

National average rates for 12-month CDs stand at 1.82% as of January 21, 2025, but many banks offer much higher rates. If you shop around, you can find banks offering 5.00% APY or more on CDs with ...

The US Food and Drug Administration (FDA) has granted fast track designation to Rznomics' RZ-001 for the treatment of ...